PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-42.34%
Both companies show declining cash positions (-42.34% vs GNPX's -61.17%). Seth Klarman would examine if this reflects broader market conditions or operational challenges.
No Data
No Data available this quarter, please select a different quarter.
-42.34%
Cash + STI yoy 0.5-0.75x GNPX's -61.17%. Martin Whitman would worry about lagging short-term reserves. Confirm debt coverage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-29.91%
Other current assets growth < half of GNPX's 2.00%. David Dodd sees a leaner approach to short-term items.
-41.98%
0.75-0.9x GNPX's -50.62%. Bill Ackman would ask if competitor is building short-term resources more aggressively.
-100.00%
Both GNPX and the company show zero PP&E (Net) Growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Less than half of GNPX's -4.04%. David Dodd sees fewer expansions in non-core assets. Possibly a simpler focus.
-100.00%
≥ 1.5x GNPX's -4.04%. David Dodd sees significantly higher long-term asset buildup. Confirm synergy with strategy.
No Data
No Data available this quarter, please select a different quarter.
-42.01%
1.25-1.5x GNPX's -36.31%. Bruce Berkowitz sees a stronger asset build. Check if it's producing returns.
-48.73%
1.1-1.25x GNPX's -38.99%. Bill Ackman wonders if the firm relies on extended payables to manage cash flow.
-46.67%
Higher Short-Term Debt Growth compared to GNPX's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-37.33%
Less than half of GNPX's 144.34%. David Dodd sees fewer expansions in other current obligations.
-39.56%
Less than half of GNPX's 13.75%. David Dodd sees a more disciplined short-term liability approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-39.56%
Less than half of GNPX's 13.75%. David Dodd sees far fewer liability expansions relative to competitor.
No Data
No Data available this quarter, please select a different quarter.
-1.24%
Below half GNPX's -2.94%. Michael Burry suspects major net losses or high dividends vs. competitor.
99.72%
Higher AOCI Growth compared to GNPX's zero value, indicating worse performance.
-100.00%
Higher Other Stockholders' Equity Items Growth compared to GNPX's zero value, indicating worse performance.
-51.92%
0.75-0.9x GNPX's -64.03%. Bill Ackman wonders if competitor is growing equity faster.
-42.01%
1.25-1.5x GNPX's -36.31%. Bruce Berkowitz checks if expansions are well-justified by ROI.
No Data
No Data available this quarter, please select a different quarter.
-46.67%
Higher Total Debt Growth compared to GNPX's zero value, indicating worse performance.
42.23%
50-75% of GNPX's 61.17%. Bruce Berkowitz notes comparatively lower net debt expansion.